SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Clive Roberts who wrote (5520)10/19/1998 5:57:00 AM
From: biodoc  Respond to of 6136
 
This has all the earmarks of a cancer cure fraud. I would be very careful. This, of course, is just my opinion.



To: Clive Roberts who wrote (5520)10/19/1998 2:32:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 6136
 
Hey, Clive..... good to hear from you. You're facing Spring while most of us are headed for shorter, wetter days?

The KCAP website doesn't inspire confidence from a medical/science perspective, and "immune adjuvants and biologic response modifiers" are frequently used catch phrases for stuff that is destined for failure.

Rick


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News